Joseph Douglas Lyon

Companies

• Corcept TherapeuticsChief Accounting Officer Jul 15, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Corcept Therapeutics CORT5,683 shares²$638.6K at $112.37Sep 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 14, 2026Sold 2,188 shares at $114.12 of Corcept Therapeutics²
• Sep 14, 2026Sold 7,812 shares at $113.32 of Corcept Therapeutics²
• Sep 14, 2026Exercised options 7,404 shares at $13.56 of Corcept Therapeutics²
• Sep 14, 2026Exercised options 2,596 shares at $11.35 of Corcept Therapeutics²
• Sep 2, 2026Shares withheld for tax 72 shares at $113.38 of Corcept Therapeutics³
• Sep 1, 2026Granted 130 shares of Corcept Therapeutics³
• Sep 1, 2026Granted 130 shares at $113.38 of Corcept Therapeutics³
• Aug 3, 2026Sold 1,540 shares at $114.16 of Corcept Therapeutics⁴
• Jun 2, 2026Shares withheld for tax 269 shares at $70.44 of Corcept Therapeutics⁵
• Jun 1, 2026Granted 537 shares of Corcept Therapeutics⁵
• Jun 1, 2026Granted 537 shares at $70.44 of Corcept Therapeutics⁵
• May 27, 2026Sold 5,000 shares at $65.00 of Corcept Therapeutics⁶
• Mar 3, 2026Shares withheld for tax 89 shares at $35.97 of Corcept Therapeutics⁷
• Mar 2, 2026Granted 398 shares of Corcept Therapeutics⁷
• Mar 2, 2026Granted 398 shares at $35.97 of Corcept Therapeutics⁷
• Dec 2, 2025Shares withheld for tax 110 shares at $79.78 of Corcept Therapeutics⁸
• Dec 1, 2025Granted 178 shares of Corcept Therapeutics⁸
• Dec 1, 2025Granted 178 shares at $79.78 of Corcept Therapeutics⁸
• Dec 1, 2025Sold 5,000 shares at $79.53 of Corcept Therapeutics⁸
• Dec 1, 2025Exercised options 5,000 shares at $13.56 of Corcept Therapeutics⁸
• Nov 3, 2025Sold 5,000 shares at $73.65 of Corcept Therapeutics⁹
• Nov 3, 2025Exercised options 5,000 shares at $13.56 of Corcept Therapeutics⁹
• Oct 1, 2025Sold 600 shares at $85.39 of Corcept Therapeutics¹⁰
• Oct 1, 2025Sold 3,473 shares at $84.92 of Corcept Therapeutics¹⁰
• Oct 1, 2025Sold 927 shares at $83.71 of Corcept Therapeutics¹⁰